Ryan Graves

Ryan Graves is an accomplished biotech entrepreneur, scientist, and commercialization manager with a robust background in the science and pharmaceutical industry.

His educational journey includes a Doctor of Philosophy (PhD) in Neuroscience from Queen Mary, University of London, a Master of Science (MSc) in Biochemistry with Distinction from the University of Otago, and a Bachelor of Science (BSc) in Biochemistry from the University of Otago.

Throughout his career, Ryan has held various key positions such as Interim CEO and Chief Technology Officer at humble bee bio, Operations Manager and Co-Founder at Rekover Therapeutics, Senior Commercialisation Manager at Wellington UniVentures, and Device Category Manager at Pharmaceutical Management Agency (PHARMAC), among others.

His expertise lies in science and technology investment, quality hypothesis-driven research, commercialization, and a deep understanding of human diseases, particularly neurological diseases and cancer.

With a passion for translating groundbreaking science into products that enhance health outcomes, Ryan has a proven track record of driving innovation and success in the biotech sector.

Ryan Graves's professional journey also includes roles such as Postdoctoral Research Fellow in Clinical Neuroscience at King's College London, Research Scientist at UCB Pharma, Research Assistant at The University of Auckland, and more, showcasing his diverse contributions to the field.

His collaborative nature and ability to connect with individuals make him an invaluable asset in bridging the gap between scientific advancements and practical applications for the betterment of society.